Search Patents
  • System and method for remote colorimetry and ratiometric comparison and quantification in analysis of medical test results
    Patent number: 11125749
    Abstract: A system for providing colorimetric and ratiometric comparison and quantification for medical test results, comprising a testing device including an alignment target and including a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a test line and a control line, and a colorimetry device configured to operate with a mobile device, the mobile device including a camera and a software application stored thereon, wherein the software application provides executable instructions to detect color properties of a color of the test line and a color of a control line of at least one of the plurality of immunoassay test strips, determine a risk value for each of at least one disease risks tested using the biologic sample, wherein the risk value is a rating determined from the color properties of the color of the test line, and provide medical test results based on the risk value.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: September 21, 2021
    Assignee: Reliant Immune Diagnostics, Inc.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Modular parallel/serial dual microfluidic chip
    Patent number: 11041185
    Abstract: A system for testing a treatment agent for a biologic material includes an input for receiving a biologic sample. A plurality of micro-pumps pump a portion of the biologic sample from the first reservoir into a connected module. A first module includes a first plurality of testing pathways for testing a first portion of the biologic sample. A first module connector removeably connects the first module to the distributor module. A second module includes a second plurality of testing pathways for testing a second portion of the biologic sample. The selected pathway applies at least one dosage level of a treatment agent to the second portion of the biologic sample. A second module connector removeably connects the second module to the distributor module, wherein treatment agent and the plurality of dosage levels tested by the system may be selected by selecting the second module associated with the second module connector.
    Type: Grant
    Filed: November 10, 2018
    Date of Patent: June 22, 2021
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Pregnancy test to assess disease risk
    Patent number: 9857373
    Abstract: A system for providing pregnancy testing in conjunction with disease risk testing, comprising a testing device having an alignment target and having a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a sample pad, a conjugate pad containing particles for conjugating with antibodies or antigens present in the biologic sample, and a membrane strip having a test line and a control line, wherein the test line and the control line are viewable, and a mobile device having a camera, a viewing screen, and a software application stored thereon, wherein the software application provides executable instructions to determine a risk value for each of at least one disease risk tested using the biologic sample, assess the risk value for each of the at least one disease risk tested, and present, if immediate medical action is required, a medical action indicator on the viewing screen.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: January 2, 2018
    Assignee: Reliant Immune Diagnostics, LLC
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Transdermal patch with separated regions for delivery of immunomodulators
    Patent number: 11369576
    Abstract: A method for creating a consolidated compound for delivering an immunomodulatory and imiquimod to a patient, comprising diluting immunomodulator extract to a desired dilution by transferring a desired quantity of the concentrated immunomodulator to an associated sterile container, the associated sterile container having a defined volume of diluted immunomodulator after dilution thereof, providing a viscous encapsulation material, selecting a prescribed amount of concentrated immunomodulator, the prescribed amount defined as that amount of the diluted immunomodulator extract required to provide a number of doses equal to the number of dispensable increments from the container containing the viscous encapsulation material, introducing the selected amount of each of the diluted immunomodulator extract into the viscous encapsulation material, introducing an amount of imiquimod into the viscous encapsulation material, and mixing the introduced amount of each of the diluted immunomodulator extracts and the introduc
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: June 28, 2022
    Assignee: AVRIO GENETICS LLC
    Inventors: James Strader, Jovan Hutton Pulitzer
  • USE OF AUTOINJECTOR FOR DISTRIBUTING ANTIGENS TO THE PUBLIC
    Publication number: 20160362205
    Abstract: A method for delivering allergens contained within single dose auto injectors to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable auto injectors that can receive a finite end amount of diluted antigens, the finite end amount comprising a single dose, dispensing from each of the sequential bulk containers a finite end amount of diluted antigen into one of the plurality of end-use sealable containers, sealing each of the end-use sealable auto injectors after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable auto injectors from each of the groups of end-use sealable auto injectors into a container comprising a kit to provide a plurality of kits for dispensing to pharmacists.
    Type: Application
    Filed: June 15, 2016
    Publication date: December 15, 2016
    Inventors: JAMES STRADER, JOVAN HUTTON PULITZER
  • PREDILUTION SETS FOR DISTRIBUTING ANTIGENS
    Publication number: 20160368626
    Abstract: A method for delivering allergens to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable containers that can receive a finite end amount of diluted antigens, dispensing from each of sequential bulk containers a finite end amount of diluted antigens into one of the plurality of end-use sealable containers, wherein the end-use seal containers filled from each of the sequential bulk containers comprises a group of end-use sealable containers associated with each of the sequential bulk containers, sealing each of the end-use containers after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable containers from each of the groups of end-use sealable containers into a container comprising a kit.
    Type: Application
    Filed: June 15, 2016
    Publication date: December 22, 2016
    Inventors: JAMES STRADER, JOVAN HUTTON PULITZER
  • PREDILUTION SETS FOR DISTRIBUTING ANTIGENS
    Publication number: 20220218819
    Abstract: A method for delivering allergens to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable containers that can receive a finite end amount of diluted antigens, dispensing from each of sequential bulk containers a finite end amount of diluted antigens into one of the plurality of end-use sealable containers, wherein the end-use seal containers filled from each of the sequential bulk containers comprises a group of end-use sealable containers associated with each of the sequential bulk containers, sealing each of the end-use containers after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable containers from each of the groups of end-use sealable containers into a container comprising a kit.
    Type: Application
    Filed: March 8, 2022
    Publication date: July 14, 2022
    Inventors: JAMES STRADER, JOVAN HUTTON PULITZER
  • Medical apparatus for testing for medical conditions including zika and pregnancy
    Patent number: 10928390
    Abstract: A system for providing immunoassay test results for multiple medical conditions, comprising a testing device having thereon an alignment target and having a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a sample pad capable of receiving a biologic sample, a conjugate pad containing particles for conjugating with antibodies or antigens present in the biologic sample, and a membrane strip having a test line and a control line, wherein the test line and the control line are viewable, and a mobile device having a camera, a viewing screen, and a software application stored thereon, wherein the software application provides executable instructions to capture an image of the testing device, process an image to determine pixel count and line intensity of the test line of each of the plurality of immunoassay test strips, and present test results on the viewing screen.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: February 23, 2021
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • PREDILUTION SETS FOR DISTRIBUTING ANTIGENS
    Publication number: 20190351051
    Abstract: A method for delivering allergens to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable containers that can receive a finite end amount of diluted antigens, dispensing from each of sequential bulk containers a finite end amount of diluted antigens into one of the plurality of end-use sealable containers, wherein the end-use seal containers filled from each of the sequential bulk containers comprises a group of end-use sealable containers associated with each of the sequential bulk containers, sealing each of the end-use containers after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable containers from each of the groups of end-use sealable containers into a container comprising a kit.
    Type: Application
    Filed: August 5, 2019
    Publication date: November 21, 2019
    Inventors: James Strader, Jovan Hutton Pulitzer
  • Microfluidic testing system with cell capture/analysis regions for processing in a parallel and serial manner
    Patent number: 11124821
    Abstract: A microfluidic chip system includes an input for receiving the biologic sample, and a first reading window for enabling a detection of the biologic material within the biologic sample. A first plurality of pathways is provided each for determining a treatment agent providing a best treatment efficacy for the predetermined biologic material. A first micro-pump is provided for pumping a portion of the biologic sample into each of the first plurality of pathways. A second plurality of pathways is provided, each for determining a dosage level of a particular one of the plurality of treatment agents with respect to the predetermined biologic material. A plurality of second micro-pumps are provided for pumping a second portion of the biologic sample into a selected one of the second plurality of pathways responsive to the determination of treatment efficacy of the treatment agent providing a best treatment of the predetermined biologic material.
    Type: Grant
    Filed: November 10, 2018
    Date of Patent: September 21, 2021
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • SYSTEM AND METHOD FOR VARIABLE FUNCTION MOBILE APPLICATION FOR PROVIDING MEDICAL TEST RESULTS USING VISUAL INDICIA TO DETERMINE MEDICAL TEST FUNCTION TYPE
    Publication number: 20180106789
    Abstract: A method for image analysis of medical test results, comprising receiving information from a mobile device application regarding a test performed using a testing device, wherein the testing device includes a plurality of immunoassay test strips and at least one test function indicator on a surface thereof, wherein the mobile device application is configured to recognize the at least one test function indicator to trigger performance of one or more of the plurality of medical test functions, receiving at the server an image of the testing device from the mobile device application, determining by the server RGB values for a plurality of pixels of the image, normalizing by the server the RGB values into a single value, comparing the single value to a control value, and providing by the server a risk indicator, wherein the risk indicator indicates a likelihood of a presence of a medical condition.
    Type: Application
    Filed: November 6, 2017
    Publication date: April 19, 2018
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Biofluidic triggering system and method
    Patent number: 11437142
    Abstract: A method of signaling a medical response action comprises receiving a biofluidic input from a client or application, by a logical testing unit, wherein the logical testing unit comprising a testing display and a persistent testing mechanism, further wherein the persistent testing mechanism comprising one or more analogical data processors, generating one or more logical results from the processing of biofluidic data from the biofluidic input, displaying, on the testing display of the logical testing unit, the one or more logical results, capturing the logical indicators on the testing display with a mobile computing unit, generating, by the mobile computing unit, a pixelated result and an action result, displaying, on the mobile display, the pixelated result and action result, responsive to a signaling input from the client or application, the mobile computing unit processes, by one or more processors, the signaling input and generating an action response packet.
    Type: Grant
    Filed: November 10, 2018
    Date of Patent: September 6, 2022
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • System and method for transmitting prescription to pharmacy using self-diagnostic test and telemedicine
    Patent number: 11915810
    Abstract: A method for initiating a telemedicine conference on a mobile device is provided. The method comprises receiving diagnostic test results in response to a diagnostic test, determining if the diagnostic test results include a positive result, storing the diagnostic test results on a server disposed on a network, presenting, if the diagnostic test results are positive, a telemedicine initiation option on a screen of the mobile device, determining whether the telemedicine initiation option is selected, sending the diagnostic test results from the server to the telemedicine provider, sending additional medical history information to the telemedicine provider, and initiating a telemedicine conference with the telemedicine provider. Some of these aspects also provide healthcare providers the ability to electronically send prescriptions and provide users the ability to use a mobile application to send prescriptions to pharmacies to be filled.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: February 27, 2024
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Communication loop and record loop system for parallel/serial dual microfluidic chip
    Patent number: 11587658
    Abstract: A method for a microfluidic testing device includes pumping a portion of a biologic sample into each of a first plurality of parallel pathways from the first reservoir using a micro-pump, applying a separate treatment agent of the plurality of treatment agents within each of the first plurality of parallel pathways to the portion of the biologic sample within the parallel pathway, pumping a second portion of the biologic sample into a selected second parallel pathway associated with a determined treatment agent of a second plurality of parallel pathways from the first reservoir using a second micro-pump, applying the determined treatment agent at a plurality of different dosage levels within the selected second parallel pathway to the second portion of the biologic sample within the selected second parallel pathway, and determining a dosage level of the plurality of different dosage levels of the determined treatment agent providing the treatment efficacy.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: February 21, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • SYSTEM AND METHOD FOR DIGITAL REMOTE PRIMARY, SECONDARY, AND TERTIARY COLOR CALIBRATION VIA SMART DEVICE IN ANALYSIS OF MEDICAL TEST RESULTS
    Publication number: 20210396750
    Abstract: A method for providing immunoassay test results includes collecting at least one biologic with a testing device, conjugating the biologic with particles on a conjugate pad of a test strip to create an immune complex, binding antigens or antibodies of the immune complex to antigens or antibodies of a test line, providing a software application to be stored on a mobile device having a camera; capturing an image of the testing device, including a color mosaic having at least one color value corresponding to a positive test result, comparing the color values of the test line image to the color values of the image of the color mosaic, determining if the color values of the image of the test line are within a predetermined range of the at least one color value of the image of the color mosaic corresponding to a positive test result; and presenting test results on the viewing screen.
    Type: Application
    Filed: September 1, 2021
    Publication date: December 23, 2021
    Inventors: Jovan Hutton PULITZER, Henry Joseph LEGERE, III, Nicholas SOLTER, Dogu Baran AYDOGAN
  • Predilution sets for distributing antigens
    Patent number: 10369215
    Abstract: A method for delivering allergens to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable containers that can receive a finite end amount of diluted antigens, dispensing from each of sequential bulk containers a finite end amount of diluted antigens into one of the plurality of end-use sealable containers, wherein the end-use seal containers filled from each of the sequential bulk containers comprises a group of end-use sealable containers associated with each of the sequential bulk containers, sealing each of the end-use containers after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable containers from each of the groups of end-use sealable containers into a container comprising a kit.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: August 6, 2019
    Assignee: Roca Medical LTD.
    Inventors: James Strader, Jovan Hutton Pulitzer
  • Predilution sets for distributing antigens
    Patent number: 10813992
    Abstract: A method for delivering allergens to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable containers that can receive a finite end amount of diluted antigens, dispensing from each of sequential bulk containers a finite end amount of diluted antigens into one of the plurality of end-use sealable containers, wherein the end-use seal containers filled from each of the sequential bulk containers comprises a group of end-use sealable containers associated with each of the sequential bulk containers, sealing each of the end-use containers after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable containers from each of the groups of end-use sealable containers into a container comprising a kit.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: October 27, 2020
    Assignee: ROCA Medical Ltd.
    Inventors: James Strader, Jovan Hutton Pulitzer
  • System and method for correlating retail testing product to medical diagnostic code
    Patent number: 11170877
    Abstract: A method for correlating a retail testing product to medical codes is provided. The method comprises receiving a diagnostic test identifier at a server disposed on a network, retrieving a first medical code from a database, wherein the first medical code is associated with the diagnostic test identifier and the retail testing product, processing an image of the retail testing product to determine results of the test, retrieving a second medical code from the database, wherein the second medical code is associated with the test results, determining a recommended pharmaceutical product useful in treatment of at least one medical condition associated with the retail testing product, retrieving a third medical code from the database, where the third medical code is associated with the recommended pharmaceutical product, and transmitting the first medical code, the second medical code, and the third medical code to a healthcare entity.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: November 9, 2021
    Assignee: RELIANT IMMUNE DIAGNOSTICS, LLC
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • System and method for variable function mobile application for providing medical test results using visual indicia to determine medical test function type
    Patent number: 11693002
    Abstract: A method for image analysis of medical test results, comprising receiving information from a mobile device application regarding a test performed using a testing device, wherein the testing device includes a plurality of immunoassay test strips and at least one test function indicator on a surface thereof, wherein the mobile device application is configured to recognize the at least one test function indicator to trigger performance of one or more of the plurality of medical test functions, receiving at the server an image of the testing device from the mobile device application, determining by the server RGB values for a plurality of pixels of the image, normalizing by the server the RGB values into a single value, comparing the single value to a control value, and providing by the server a risk indicator, wherein the risk indicator indicates a likelihood of a presence of a medical condition.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: July 4, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • System and method for digital remote primary, secondary, and tertiary color calibration via smart device in analysis of medical test results
    Patent number: 11112406
    Abstract: A method for providing immunoassay test results includes collecting at least one biologic with a testing device, conjugating the biologic with particles on a conjugate pad of a test strip to create an immune complex, binding antigens or antibodies of the immune complex to antigens or antibodies of a test line, providing a software application to be stored on a mobile device having a camera; capturing an image of the testing device, including a color mosaic having at least one color value corresponding to a positive test result, comparing the color values of the test line image to the color values of the image of the color mosaic, determining if the color values of the image of the test line are within a predetermined range of the at least one color value of the image of the color mosaic corresponding to a positive test result; and presenting test results on the viewing screen.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: September 7, 2021
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III, Nicholas Solter, Dogu Baran Aydogan
Narrow Results

Filter by US Classification